Anaesthetic management of 27 cases of boron neutron capture therapy for glioblastoma
β Scribed by T. Shinomura; H. Furutani; M. Osawa; K. Ono; K. Fukuda
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 89 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0003-2409
No coin nor oath required. For personal study only.
β¦ Synopsis
Twentyβseven patients received boron neutron capture therapy during craniotomy at our research reactor from 1991 to 1999. This is a form of intraβoperative radiation therapy, which uses neutrons from a nuclear reactor. There are three additional major problems to anaesthetists: boron neutron capture therapy must be given beside the nuclear reactor, with no hospital facilities; neutrons cannot be shielded effectively by ordinary protectors; and neutrons are detrimental to metal devices and especially to electrical appliances. Boron neutron capture therapy has been adopted as an effective therapy for glioblastoma/astrocytoma, but special considerations are required for anaesthesia.
π SIMILAR VOLUMES
3, -p-carborane-l-yl)propyl]-6-phenyl phenanthridinium chloride hydrochloride (13) has been synthesised by reacting 3,8-diacetamido-6-phenylphenanthridine ) in nitrobenzene at 120Β°C for 4 days and subsequent removal of the protective groups using 33% HBr/AcOH. Conversion to the chloride hydrochlori